Gene polymorphisms of tumor necrosis factor and the susceptibility to nasopharyngeal carcinoma in Han population in Southwest China

Journal of Clinical Rehabilitative Tissue Engineering Research

Volumn 11, Issue 34, 2007, Pages 6819-6822

  Zhang, Bei Lei ^a,b   Liang, Wei Bo ^a   Ran, Peng ^a   Zhou, B ^a   Wei, Y S ^a   Zhang, G Q ^a   Wang, J ^a   Zhang, Lin ^a  

^a SICHUAN UNIVERSITY   (China)

^b XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIOPSY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHINA; CONTROLLED STUDY; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NASOPHARYNX CARCINOMA; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 34548803669     PISSN: 16738225     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Wilson AG, Symons JA, McDowell TL, et al. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 1997;94(7):3195-3199
2. Chinese source.
3. Chinese source.
4. Mauceri HJ, Seetharam S, BeckettMA, et al. Tumor production of angiostatin is enhanced after exposure to TNF-alpha. Int J Cancer 2002;97(4):410-415
5. Gutman M, Inbar M, Lev-Shlush D, et al. High dose tumor necrosis factor-alpha and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservation. Cancer 1997;79(6):1129-1137
6. Mueller H. Tumour necrosis factor as an antineoplasticagent: pitfalls and promises. Cell Mol Life Sci 1998;54(12):1291-1298
7. Mocellin S, Rossi CR, Pilati P. et al. Tumor necrosis factor, cancer and anticancer therapy. Cytokine Growth Factor Rev 2005; 16(1):35-53
8. Singh KK, Schmidtke J. Single nucleotide polymorphisms within the promoter region of the rhesus monkey tumor necrosis factor-alpha gene, Immunogenetics 2005;57(3-4):289-292
9. Nikolova PN, Pawelec GP, Mihailova SM, et al. Association of cytokine gene polymorphisms with malignant melanoma in Caucasian population. Cancer Immunol Immunother 2007;56(3):371-379
10. keguchi M, Iwamoto A, Taniguchi K,et al. The gene expression level of transforming growth factor-beta (TGF-beta) as a biological prognostic marker of hepatocellular carcinoma. J Exp Clin Cancer Res 2005;24(3): 415-421
11. Skerrett DL, Moore EM, Bernstein DS, et al. Cytokine genotype polymorphisms in breast carcinoma: associations of TGF-beta1 with relapse. Cancer Invest 2005;23(3):208-214
12. Chinese source.
13. He B, NavikasV, Lundahl J, et al. Tumor necrosis factor alpha-308 alleles in multiple sclerosis and optic neuritis. J Neuroimmunol 1995;63(2):143-147
14. Guo W, Wang N, Li Y, et al. Polymorphisms in tumour necrosis factor genes and susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in a population of high incidence region of North China. Chin Med J (Engl) 2005; 118(22):1870-1878
15. Oh BR, Sasaki M, Perinchery G, et al. Frequent genotype changes at-308 and-488 regions of the tumour necrosis factor-alpha (TNF-alpha) gene in patients with prostate cancer.J Urol 2000;163(5):1584-1587
16. Buch MH, Seto Y, Bingham SJ, et al. C-reactive protein as a predictor of infliximab treatment outcome in patients with rheumatoid arthritis: defining subtypes of nonresponse and subsequent response to etanercept. Arthritis Rheum 2005;52(1):42-48
17. Tsai MH, Chen WC, Tsai FJ, et al. Correlation of p21 gene codon 31 polymorphism and TNF-alpha gene polymorphism with nasopharyngeal carcinoma. J Clin Lab Anal 2002;16(3):146-150
18. Riha H, Hubacek JA, Poledne R, et al. IL-10 and TNF-beta gene polymorphisms have no major influence on lactate levels after cardiac surgery. Eur J Cardiothorac Surg 2006;30(1):54-58
19. Balakrishnan VS, Guo D, Rao M,et al. Cytokine gene polymorphisms in hemodialysis patients: association with comorbidity, functionality, and serum albumin. Kidney Int 2004;65(4):1449-1460